Welcome to LookChem.com Sign In|Join Free

CAS

  • or
OLDA, or N-Oleoyldopamine, is a bioactive lipid that is naturally found in the mammalian brain. It selectively activates the transient receptor potential vanilloid type 1 (TRPV1) channel and also functions as a 5-lipoxygenase inhibitor. OLDA plays a significant role in various physiological processes and has potential applications in different industries due to its unique properties.

105955-11-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 105955-11-1 Structure
  • Basic information

    1. Product Name: OLDA
    2. Synonyms: (9Z)-N-[2-(3,4-DIHYDROXYPHENYL)ETHYL]-9-OCTADECENAMIDE;N-[2-(3,4-DIHYDROXYPHENYL)ETHYL]9Z-OCTADECENAMIDE;OLDA;ODA;N-OLEOYLDOPAMINE;N-Oleoyldopamine (OLDA);(Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]octadec-9-enamide
    3. CAS NO:105955-11-1
    4. Molecular Formula: C26H43NO3
    5. Molecular Weight: 417.62
    6. EINECS: N/A
    7. Product Categories: Vanilloid/TRPV channel
    8. Mol File: 105955-11-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 619.5 °C at 760 mmHg
    3. Flash Point: 328.4 °C
    4. Appearance: white/powder
    5. Density: 1.004 g/cm3
    6. Vapor Pressure: 6.13E-16mmHg at 25°C
    7. Refractive Index: 1.521
    8. Storage Temp.: −20°C
    9. Solubility: DMSO: ~20 mg/mL, soluble
    10. CAS DataBase Reference: OLDA(CAS DataBase Reference)
    11. NIST Chemistry Reference: OLDA(105955-11-1)
    12. EPA Substance Registry System: OLDA(105955-11-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 105955-11-1(Hazardous Substances Data)

105955-11-1 Usage

Uses

Used in Pharmaceutical Industry:
OLDA is used as a selective activator for the TRPV1 channel, which is involved in various physiological processes, including pain sensation, body temperature regulation, and inflammation. This application is particularly relevant for the development of drugs targeting conditions such as chronic pain, migraine, and inflammatory disorders.
OLDA is also used as a 5-lipoxygenase inhibitor, which plays a crucial role in the production of leukotrienes, inflammatory mediators involved in asthma and other inflammatory diseases. In this application, OLDA can be utilized in the development of anti-inflammatory and anti-asthmatic medications.
Used in Neurological Research:
In the field of neurological research, OLDA can be used as a tool to study the TRPV1 channel's role in various brain functions and disorders. Understanding the channel's activation by OLDA can provide insights into the development of novel therapeutic strategies for neurological conditions such as epilepsy, neuropathic pain, and neurodegenerative diseases.
Used in Cosmetics Industry:
Due to its bioactive properties, OLDA can be used in the cosmetics industry as an ingredient in anti-aging and skin care products. Its ability to activate the TRPV1 channel may contribute to improved skin health and appearance by promoting blood circulation and reducing inflammation.

Biological Activity

Potent endogenous vanilloid TRPV1 (VR1) receptor agonist (EC 50 = 36 nM at hVR1) with low affinity for rCB 1 receptors (K i = 1.6 μ M). Potently induces VR1-mediated thermal hyperalgesia in rats in vivo .

Check Digit Verification of cas no

The CAS Registry Mumber 105955-11-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,9,5 and 5 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 105955-11:
(8*1)+(7*0)+(6*5)+(5*9)+(4*5)+(3*5)+(2*1)+(1*1)=121
121 % 10 = 1
So 105955-11-1 is a valid CAS Registry Number.
InChI:InChI=1/C26H43NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-26(30)27-21-20-23-18-19-24(28)25(29)22-23/h9-10,18-19,22,28-29H,2-8,11-17,20-21H2,1H3,(H,27,30)/b10-9-

105955-11-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Oleoyldopamine

1.2 Other means of identification

Product number -
Other names (E)-N-[2-(3,4-dihydroxyphenyl)ethyl]octadec-9-enamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105955-11-1 SDS

105955-11-1Downstream Products

105955-11-1Relevant articles and documents

A Convenient Protocol for the Synthesis of Fatty Acid Amides

Johansson, Silje J. R.,Johannessen, Tonje,Ellefsen, Christiane F.,Ristun, Mali S.,Antonsen, Simen,Hansen, Trond V.,Stenstrom, Yngve,Nolsoe, Jens M. J.

, p. 213 - 217 (2019)

Several classes of biologically occurring fatty acid amides have been reported from mammalian and plant sources. Many amides conjugated with fatty acids of mammalian origin exhibit specific activation of individual receptors. Their potential as pharmacological tools or as lead compounds towards the development of novel therapeutics is of great interest. Hence, access to such amides by a practical, high-yielding and scalable protocol without affecting the geometry or position of sensitive functionalities is needed. A protocol that meets all these requirements involves activation of the corresponding acid with carbonyl diimidazole (CDI) followed by reaction with the desired amine or its hydrochloride. More than fifty compounds have been prepared in generally high yields.

Synthesis and evaluation of fatty acid amides on the N-oleoylethanolamide-like activation of peroxisome proliferator activated receptor α

Takao, Koichi,Noguchi, Kaori,Hashimoto, Yosuke,Shirahata, Akira,Sugita, Yoshiaki

, p. 278 - 285 (2015/04/22)

A series of fatty acid amides were synthesized and their peroxisome proliferator-activated receptor α (PPAR-α) agonistic activities were evaluated in a normal rat liver cell line, clone 9. The mRNAs of the PPAR-α downstream genes, carnitine-palmitoyltransferase-1 and mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase, were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR) as PPAR-α agonistic activities. We prepared nine oleic acid amides. Their PPAR-α agonistic activities were, in decreasing order, N-oleoylhistamine (OLHA), N-oleoylglycine, Oleamide, N-oleoyltyramine, N-oleoylsertonin, and Olvanil. The highest activity was found with OLHA. We prepared and evaluated nine N-acylhistamines (N-acyl-HAs). Of these, OLHA, C16:0-HA, and C18:1Δ9-trans-HA showed similar activity. Activity due to the different chain length of the saturated fatty acid peaked at C16:0-HA. The PPAR-α antagonist, GW6471, inhibited the induction of the PPAR-α downstream genes by OLHA and N-oleoylethanolamide (OEA). These data suggest that N-acyl-HAs could be considered new PPAR-α agonists.

Evaluation of endogenous fatty acid amides and their synthetic analogues as potential anti-inflammatory leads

Dang, Hung The,Kang, Gyeoung Jin,Yoo, Eun Sook,Hong, Jongki,Choi, Jae Sue,Kim, Hyung Sik,Chung, Hae Young,Jung, Jee H.

experimental part, p. 1520 - 1527 (2011/03/23)

A series of endogenous fatty acid amides and their analogues (1-78) were prepared, and their inhibitory effects on pro-inflammatory mediators (NO, IL-1β, IL-6, and TNF-α) in LPS-activated RAW264.7 cells were evaluated. Their inhibitory activity on the pro-inflammatory chemokine MDC in IFN-γ-activated HaCaT cells was also examined. The results showed that the activity is strongly dependent on the nature of the fatty acid part of the molecules. As expected, the amides derived from enone fatty acids showed significant activity and were more active than those derived from other types of fatty acids. A variation of the amine headgroup also altered bioactivity profile remarkably, possibly by modulating cell permeability. Regarding the amine part of the molecules, N-acyl dopamines exhibited the most potent activity (IC50 ~2 μM). This is the first report of the inhibitory activity of endogenous fatty acid amides and their analogues on the production of nitric oxide, cytokines (IL-1β, IL-6, and TNF-α) and the chemokine MDC. This study suggests that the enone fatty acid-derived amides (such as N-acyl ethanolamines and N-acyl amino acids) and N-acyl dopamines may be potential anti-inflammatory leads.

Inhibition of in vitro prostaglandin and leukotriene biosyntheses by cinnamoyl-β-phenethylamine and N-acyldopamine derivatives

Tseng,Iwakami,Mikajiri,Shibuya,Hanaoka,Ebizuka,Padmawinata,Sankawa

, p. 396 - 400 (2007/10/02)

N-trans- and N-cis-Feruloyltyramines were isolated as the inhibitors of in vitro prostaglandin (PG) synthesis from an Indonesian medicinal plant, Ipomoea aquatica (Convolvulaceae). In order to clarify structure activity relationships, cinnamoyl-β-phenethylamines with possible combinations of naturally occurring cinnamic acids and β-phenethylamines were synthesized and tested for their inhibitory activities against PG synthetase and arachidonate 5-lipoxygenase. The compounds containing catechol groups such as N-caffeoyl-β-phenethylamine (CaP) showed higher inhibitory effects on PG synthetase. The catechol group was found to M essential for the inhibition of arachidonate 5-lipoxygenase. The investigation of concentration dependent effects on PG biosynthesis revealed that CaP enhanced PG biosynthesis at a lower concentration range, whereas it inhibited the reaction at a higher concentration. The effects of CaP on each reaction step were investigated with purified PG endoperoxide synthase and microsomal PG synthetase. CaP inhibited the cyclooxygenase reaction, while it enhanced the hydroperoxidase reaction. N-Acyldopamines which contain catechol and lipophylic group were synthesized from dopamine and fatty acids to test their inhibitory effects on arachidonate 5-lipoxygenase. N-Linoleoyldopamine was the most active compound and its IC50 value was 2.3 nM in our assay system, in which an IC50 value of AA 861, a specific inhibitor of 5-lipoxygenase, was 8 nM.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105955-11-1